基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the complete record of transactions filed by Haurwitz Rachel E., Présidente et Directrice Générale. Insider active across 2 companies, notably Caribou Biosciences, Inc.. Aggregated, 12 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €19k. Activity tracked since 26 January 2022. The latest transaction was disclosed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Haurwitz Rachel E. is President and CEO. She has 12 filings in total, and across the recent filings recorded between 2022-01-27 and 2026-02-20, the buy amount is EUR 18792, with no sells reported. The recent filings concern Caribou Biosciences, Inc. and Seer, Inc., with transactions of Attribution nature.